1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804

Download real time

1151.50 16.80 (1.48%)

27.67% Fall from 52W High

488.5K NSE+BSE Volume

NSE 16 Apr, 2025 10:50 AM (IST)

Watchlist

Portfolio

Alert

Share
14S
4W
6O
4T
66,879.3

Market Cap

High in industry
19.2

PE TTM

Below industry Median
0.7

PEG TTM

PEG TTM is less than 1
2.2

Price to Book

Below industry Median
0.8

Beta 1Year

Very Low volatility
US FDA Approval
Aurobindo Pharma gets US FDA approval to produce Rivaroxaban tablets with a market size of $8.5 bn See details


Aurobindo Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Aurobindo Pharma Ltd. from all sources in a single place.

Is Aurobindo Pharma Ltd. worth buying?
1240 Votes:
Buy 80.16%
Sell 13.79%
Hold 6.05%
BUY
SELL
HOLD